CLUSTER filed Apr 26, 2026 at 20:00 ET
Two C-suite executives at Natera (President of Clinical Diagnostics and President/Chief Business Officer) sold a combined $360K in open-market sales on April 27, 2026, at $203.75 per share. This follows a broader cluster of insider selling by the CEO, directors, and other officers totaling ~$1.5M over the prior week. While the dollar amount is trivial relative to Natera's $28.6B market cap (0.0013%), the concentration of selling by senior leadership near the stock's recent highs warrants attention.